The a2 Milk Company (ATM) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
12 Jan, 2026Opening remarks and agenda
Chair welcomed shareholders in Auckland and online, confirmed quorum, and introduced directors, management, auditors, and share registry representatives.
Apologies were received from a Shanghai-based director; the agenda included board and CEO addresses, resolutions, and Q&A.
Financial performance review
FY24 revenue reached NZD 1.68 billion, up 5.2%, with EBITDA at NZD 234.3 million (6.9% increase) and net profit after tax at NZD 167.6 million (7.7% increase).
China and Asia segment drove 14.1% growth, now over two-thirds of total sales; ANZ segment declined 14.6% due to distribution changes.
Liquid milk sales grew 3.3% in Australia and 7.4% in the U.S.; other nutritionals grew 36.7%.
Net cash position improved to NZD 968.9 million, with operational cash conversion at 126%.
Achieved record China label IMF market share and became a top-5 China IMF brand.
Board and executive committee updates
Chair emphasized board renewal and succession planning, with recent appointments of Antonio Rivera and Lain Jager, and the resignation of David Wang.
Warwick Every-Burns retired after eight years, with acknowledgments for his contributions.
CEO David Bortolussi and new director Antonio Rivera addressed shareholders, highlighting their backgrounds and strategic focus.
Latest events from The a2 Milk Company
- Double-digit revenue and profit growth, record market share, and special dividend planned.ATM
H1 202616 Feb 2026 - Strong China growth, supply chain gains, and higher profit set steady outlook for FY 2025.ATM
H2 20241 Feb 2026 - Upgraded FY2025 outlook after 10% revenue growth, new launches, and first interim dividend.ATM
H1 202514 Dec 2025 - Record sales, supply chain overhaul, and robust outlook driven by China and new products.ATM
H2 202523 Nov 2025 - Record sales, supply chain transformation, and a $300M special dividend headline the AGM.ATM
AGM 202520 Nov 2025